Peak Bio, Inc. (PKBO)

OTCMKTS: PKBO · Delayed Price · USD

0.0052

0.00 (0.00%)

Apr 1, 2024, 2:22 PM EDT - Market open

Peak Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021
Revenue	0.61	0.53
Revenue Growth (YoY)	15.02%	-
Cost of Revenue	0	0
Gross Profit	0.61	0.53
Selling, General & Admin	8.53	2.47
Research & Development	3.92	7.12
Other Operating Expenses	-0.82	0
Operating Expenses	12.46	9.59
Operating Income	-11.85	-9.07
Interest Income	0	0
Interest Expense	0.05	0.01
Other Expense / Income	1.27	-0.87
Pretax Income	-13.16	-8.21
Income Tax	-0.07	0.08
Net Income	-13.09	-8.29
Shares Outstanding (Basic)	18	17
Shares Outstanding (Diluted)	18	17
Shares Change	3.20%	-
EPS (Basic)	-0.74	-0.48
EPS (Diluted)	-0.74	-0.48
Free Cash Flow	-7.63	-8.87
Free Cash Flow Per Share	-0.43	-0.52
Gross Margin	99.98%	100.00%
Operating Margin	-1949.68%	-1715.95%
Profit Margin	-2153.88%	-1569.65%
Free Cash Flow Margin	-1255.24%	-1679.72%
EBITDA	-11.88	-8.89
EBITDA Margin	-1954.70%	-1682.49%
Depreciation & Amortization	0.79	0.18
EBIT	-12.66	-9.07
EBIT Margin	-2084.12%	-1715.92%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.